Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLECLUMAB vs OLUTASIDENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLECLUMAB vs OLUTASIDENIB: Safety Overview

Metric OLECLUMAB OLUTASIDENIB
Total FAERS Reports 118 210
Deaths Reported 14 27
Death Rate 11.9% 12.9%
Hospitalizations 102 85
Average Patient Age 63.4 yrs 66.2 yrs
% Female Patients 41.7% 46.3%
FDA Approval Date N/A Dec 1, 2022
Manufacturer N/A Rigel Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription